IL1B and Alzheimer disease: We hypothesized that, although IL-1β is not traditionally associated with Th2-driven inflammation in AD, it could still contribute to disease progression through its effects on skin barrier dysfunction and early immune responses, especially in the context of co-morbid allergic conditions.